Condensed Consolidated Statements of Cash Flows (USD $) In Thousands	6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010
Reconciliation of net loss to cash provided by operating activities:
Net Loss	$ (1,876)	$ (16,093)
Add (deduct):
Depreciation and amortization	9,592	11,613
Provision for bad debt	1,144	2,946
Investment and other losses (gains) - net	1,101	(10,708)
Payments for title losses in excess of provisions	(972)	(10,979)
Insurance recoveries of title losses	2,605	5,802
Decrease in receivables - net	4,930	34,168
Increase in other assets - net	(3,350)	(4,454)
Decrease in payables and accrued liabilities - net	(17,680)	(10,500)
(Decrease) increase in net deferred income taxes	(4,293)	609
Net earnings from equity investees	(653)	(637)
Dividends received from equity investees	1,110	1,231
Other - net	1,832	2,645
Cash (used) provided by operating activities	(6,510)	5,643
Investing activities:
Proceeds from investments available-for-sale matured and sold	140,560	119,513
Purchases of investments available-for-sale	(148,407)	(91,675)
Proceeds from redemptions of investments - pledged		217,225
Purchases of property and equipment and title plants - net	(11,108)	(3,828)
Increases in notes receivable	(174)	(285)
Collections on notes receivable	617	537
Change in cash and cash equivalents due to sale and deconsolidation of subsidiaries (see below)		(1,844)
Cash paid for loan guarantee obligation	(3,928)
Net cash received for other assets, cost-basis investments, equity investees and other	10	4,744
Cash (used) provided by investing activities	(22,430)	244,387
Financing activities:
Payments on notes payable	(1,639)	(5,458)
Payments on line of credit		(216,141)
Proceeds from notes payable	500	134
Distributions to noncontrolling interests	(2,613)	(2,879)
Cash used by financing activities	(3,752)	(224,344)
Effects of changes in foreign currency exchange rates	887	(853)
(Decrease) increase in cash and cash equivalents	(31,805)	24,833
Cash and cash equivalents at beginning of period	154,490	116,100
Cash and cash equivalents at end of period	122,685	140,933
Supplemental information:
Settlement of wage and hour litigation through issuance of common stock	7,582
Settlement of note payable through issuance of Common Stock held in treasury	1,299
Changes in financial statement amounts due to sale and deconsolidation of subsidiaries:
Note receivable		2,500
Investments in investees, on an equity method basis		5,316
Goodwill		(5,831)
Title plants		(1,048)
Property and equipment, net of accumulated depreciation		(1,560)
Intangible asset, net of amortization		2,827
Other - net		(878)
Liabilities		1,344
Noncontrolling interests		336
Investment and other gains - net		(1,162)
Change in cash and cash equivalents due to sale and deconsolidation of subsidiaries		$ 1,844